Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 186

    Building speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo

    Building speciality portfolio of around 150 products in next 3 fiscal yrs: Aurobindo

    Medical Dialogues Bureau8 Jan 2019 12:10 PM IST
    New Delhi: Aurobindo Pharma is focussing on building a diverse speciality portfolio of nearly 150 products with an addressable market size of USD...
    Takeda unlikely to sell OTC drug business - CEO

    Takeda unlikely to sell OTC drug business - CEO

    Medical Dialogues Bureau8 Jan 2019 9:08 AM IST
    TOKYO - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a...
    Fighting Parkinsons: Medica Hospital to launch new treatment in eastern India

    Fighting Parkinsons: Medica Hospital to launch new treatment in eastern India

    Farhat Nasim7 Jan 2019 12:06 PM IST
    Apomorphine is a highly selective Dopamine receptor emulator, which promotes the release of Dopamine in the brain from the nerve cells, explained Dr...
    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Farhat Nasim7 Jan 2019 9:45 AM IST
    Lupin's Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg is the generic version of Sunovion Pharmaceuticals, Inc's Latuda...
    Dire need to improve medical infrastructure in country: ICJ India member

    Dire need to improve medical infrastructure in country: ICJ India member

    Farhat Nasim7 Jan 2019 9:30 AM IST
    An Indian member of the International Court of Justice Dalveer Bhandari said there was a "dire need" to make healthcare affordable for all and improve...
    Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants

    Rs 8100 crore bank loan fraud case: Sterling Biotech receives non bailable warrants

    Medical Dialogues Bureau7 Jan 2019 9:15 AM IST
    Additional Sessions Judge Satish Kumar Arora allowed the Enforcement Directorate's plea seeking issuance of NBW against Sterling Biotech Ltd (SBL)...
    Merck KEYTRUDA receives five new approvals in Japan

    Merck KEYTRUDA receives five new approvals in Japan

    Farhat Nasim7 Jan 2019 9:00 AM IST
    KEYTRUDA is the First Anti-PD-1 Approved in Japan for the First-Line Treatment of Advanced NSCLC as Both Monotherapy and in Combination with...
    Rs 11000 crore benefit to people from fixing drug prices: Minister

    Rs 11000 crore benefit to people from fixing drug prices: Minister

    Medical Dialogues Bureau6 Jan 2019 9:35 AM IST
    The Minister, who was replying during the Question Hour, said that to make medicines affordable, the government capped prices of 855 medicines and...
    PharmaHopers launches derma franchise category for B2B businesses

    PharmaHopers launches derma franchise category for B2B businesses

    Farhat Nasim6 Jan 2019 9:15 AM IST
    PharmaHopers has a number of dermatology companies listed which are involved in the marketing and manufacturing of derma products like Acne and...
    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Medical Dialogues Bureau6 Jan 2019 9:00 AM IST
    The drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
    PMBJP Kendras: Unbranded generic medicines worth Rs 417 crore sold till 2018

    PMBJP Kendras: Unbranded generic medicines worth Rs 417 crore sold till 2018

    Farhat Nasim5 Jan 2019 10:45 AM IST
    Unbranded generic medicines worth Rs 417 crore have been sold through PMBJP Kendras from the inception of the scheme till the end of December 2018,...
    Johns Hopkins University, Bristol-Myers must face 1 Billion Dollar syphilis infections suit

    Johns Hopkins University, Bristol-Myers must face 1 Billion Dollar syphilis infections suit

    Farhat Nasim5 Jan 2019 9:30 AM IST
    U.S: A federal judge in Maryland said The Johns Hopkins University, Bristol-Myers Squibb Co and the Rockefeller Foundation must face a $1 billion...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok